RecruitingPhase 2NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Sponsor: AbbVie
Amarillo, TX · Austin, TX · Bellaire, TX · +56 more sites
Obesity clinical trials in Dallas, TX
28 recruiting obesity studies with a site in Dallas, TX.
RecruitingPhase 3NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Sponsor: Hoffmann-La Roche
Bellaire, TX · Brownsville, TX · Corpus Christi, TX · +41 more sites
RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Dallas, TX · Houston, TX · Humble, TX · +53 more sites
RecruitingPhase 3NCT07823608
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
Sponsor: Pfizer
Dallas, TX · Tomball, TX · +4 more sites
RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Amarillo, TX · Austin, TX · +137 more sites
RecruitingPhase 2NCT07589608
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Austin, TX · Dallas, TX · Houston, TX · +37 more sites
RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
Austin, TX · Brownsville, TX · Dallas, TX · +77 more sites
RecruitingPhase 1NCT07808073
A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Sponsor: Eli Lilly and Company
Dallas, TX · +1 more sites
RecruitingPhase 2NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Austin, TX · Dallas, TX · +47 more sites
RecruitingPhase 3NCT07684235
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Sponsor: Amgen
Austin, TX · Bellaire, TX · Dallas, TX · +68 more sites
RecruitingNot applicableNCT06003686
Spinal Cord Injury Model Systems (SCIMS) - Education Module
Sponsor: University of Miami
Dallas, TX · +2 more sites
RecruitingPhase 3NCT07533175
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Dallas, TX · Houston, TX · +13 more sites
RecruitingPhase 3NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · +96 more sites
RecruitingPhase 3NCT07668414
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · Brownsville, TX · +42 more sites
RecruitingPhase 3NCT07339423
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Sponsor: Novo Nordisk A/S
Amarillo, TX · Dallas, TX · Forney, TX · +19 more sites
RecruitingPhase 3NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · +38 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Amarillo, TX · Austin, TX · Conroe, TX · +118 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · Houston, TX · +36 more sites
RecruitingEarly Phase 1NCT04838678
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
RecruitingNot applicableNCT05028309
Effects of Obesity in the Aged
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
RecruitingNot applicableNCT06932250
Leg Heating in Pregnant Women With Obesity
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
RecruitingNot applicableNCT05147909
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
RecruitingPhase 2NCT06517212
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
Sponsor: Baylor Research Institute
Dallas, TX
RecruitingPhase not listedNCT07075341
Healthy Living BEYOND Weight Study
Sponsor: American Heart Association
Dallas, TX
Not yet recruitingNot applicableNCT07713836
Nutrition Intervention Optimization to Better Utilize Resources and Support Health
Sponsor: Tufts University
Dallas, TX
Not yet recruitingPhase 3NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · +52 more sites
Not yet recruitingPhase not listedNCT07648901
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain Injury
Sponsor: Baylor Research Institute
Dallas, TX
Not yet recruitingPhase 3NCT07400107
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Dallas, TX · Shavano Park, TX · +8 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.